PODO Debuts Predictive Platform for Cancer Care at AACR 2025
April 16, 2025
Organoid-Based Precision Medicine Technology Demonstrates Pre-Treatment Assessment of Cancer Therapy Responses PODO Therapeutics, a precision medicine-focused biotechnology company, today announced that it will present its